Recent Research | Page 75 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journalsort ascending Bone Marrow Disease
Why are myelodysplastic syndromes unrecognized and underdiagnosed?: a primary care perspective Jul 2012 Am J Med myelodysplastic syndromes (MDS)
Commentary on "clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes" Jul 2012 Am J Med myelodysplastic syndromes (MDS)
The value of survival gains in myelodysplastic syndromes. Jan 2017 Am J Manag Care myelodysplastic syndromes (MDS)
The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria Feb 2012 Am J Hum Genet paroxysmal nocturnal hemoglobinuria (PNH)
Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia Jun 2014 Am J Hematol aplastic anemia
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution Apr 2014 Am J Hematol myelodysplastic syndromes (MDS)
Assessment of Human Antihuman Antibodies to Eculizumab After Long-Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria Dec 2015 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia. Oct 2013 Am J Hematol aplastic anemia
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: A treatment versus no-treatment study Dec 2015 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. Oct 2013 Am J Hematol myelodysplastic syndromes (MDS)